Aurinia Pharmaceuticals Inc(AUPH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AUPH Aurinia Pharmaceuticals Inc

休市中 08-23 16:00:00 EDT

6.76

+0.11

+1.65%

盘后6.76

+0.000.00%

19:51 EDT

最高6.94	最低6.62	成交量170.15万
今开6.67	昨收6.65	日振幅4.81%
总市值9.67亿	流通市值8.69亿	总股本1.43亿
成交额1,155万	换手率1.32%	流通股本1.29亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AUPH","market":"US","secType":"STK","nameCN":"Aurinia Pharmaceuticals Inc","latestPrice":6.76,"timestamp":1724443200000,"preClose":6.65,"halted":0,"volume":1701506,"hourTrading":{"tag":"盘后","latestPrice":6.76,"preClose":6.76,"latestTime":"19:51 EDT","volume":33773,"amount":228304.31,"timestamp":1724457090852},"delay":0,"floatShares":128515425,"shares":142990974,"eps":-0.354683,"marketStatus":"休市中","marketStatusCode":7,"change":0.11,"latestTime":"08-23 16:00:00 EDT","open":6.67,"high":6.94,"low":6.62,"amount":11551764.146346,"amplitude":0.04812,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.354683,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":951454800000,"adjPreClose":6.65,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":6.74,"preClose":6.65,"latestTime":"09:00 EDT","volume":170,"amount":1145.2000189999999,"timestamp":1724418006428},"postHourTrading":{"tag":"盘后","latestPrice":6.76,"preClose":6.76,"latestTime":"19:51 EDT","volume":33773,"amount":228304.31,"timestamp":1724457090852},"volumeRatio":0.8777135516088944,"impliedVol":0.5495,"impliedVolPercentile":0.1746},"requestUrl":"/m/hq/s/AUPH/tweets","defaultTab":"tweets","newsList":[{"id":"2458341988","title":"Aurinia Pharmaceuticals Inc2024财年第二财季实现净利润722000.00美元，同比增加106.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458341988","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458341988?lang=zh_cn&edition=full","pubTime":"2024-08-09 00:22","pubTimestamp":1723134174,"startTime":"0","endTime":"0","summary":"8月9日，Aurinia Pharmaceuticals Inc公布财报，公告显示公司2024财年第二财季净利润为722000.00美元，同比增加106.28%；其中营业收入为57.19百万美元，同比增加37.84%，每股基本收益为0.01美元。机构评级：截至2024年8月9日，当前有7家机构对Aurinia Pharmaceuticals Inc目标价做出预测，其中目标均价为9.57美元，其中最低目标价为6.00美元，最高目标价为13.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408090022579f1afcfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408090022579f1afcfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AUPH"],"gpt_icon":0},{"id":"2457005096","title":"Aurinia Pharmaceuticals Inc盘中异动 急速拉升5.03%报5.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457005096","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457005096?lang=zh_cn&edition=full","pubTime":"2024-08-07 03:53","pubTimestamp":1722974004,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日03时53分，Aurinia Pharmaceuticals Inc股票出现异动，股价大幅上涨5.03%。截至发稿，该股报5.64美元/股，成交量134.223万股，换手率0.94%，振幅8.29%。Aurinia Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为1.29%。Aurinia Pharmaceuticals Inc公司简介：Aurinia Pharmaceuticals Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807035324aefd8a12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807035324aefd8a12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AUPH"],"gpt_icon":0},{"id":"2456424744","title":"Aurinia Pharmaceuticals Inc: Leerink Partners将目标价从15美元降至11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456424744","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456424744?lang=zh_cn&edition=full","pubTime":"2024-08-02 15:24","pubTimestamp":1722583463,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","AUPH"],"gpt_icon":0},{"id":"2455156537","title":"Aurinia Pharmaceuticals Inc盘中异动 早盘股价大涨5.16%报5.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455156537","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455156537?lang=zh_cn&edition=full","pubTime":"2024-07-31 23:08","pubTimestamp":1722438481,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日23时08分，Aurinia Pharmaceuticals Inc股票出现波动，股价快速拉升5.16%。截至发稿，该股报5.91美元/股，成交量60.0126万股，换手率0.42%，振幅4.98%。Aurinia Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为1.17%。其相关个股中，Renovaro Inc.、Zevra Therapeutics, Inc.、Applied Therapeutics, Inc.涨幅较大，Bionomics Ltd Ads Each Rep 180 Ord Shs、Salarius Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为135.92%、124.70%、122.54%，振幅较大的相关个股有Renovaro Inc.、Alpha Tau Medical Ltd C/Wts 、Salarius Pharmaceuticals, Inc.，振幅分别为79.10%、44.12%、40.61%。Aurinia Pharmaceuticals Inc公司简介：Aurinia Pharmaceuticals Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731230801941fca15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731230801941fca15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AUPH","BK4139"],"gpt_icon":0},{"id":"2453719871","title":"Aurinia Pharmaceuticals Inc盘中异动 下午盘股价大跌5.13%报5.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453719871","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453719871?lang=zh_cn&edition=full","pubTime":"2024-07-23 02:04","pubTimestamp":1721671464,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日02时04分，Aurinia Pharmaceuticals Inc股票出现波动，股价大幅下跌5.13%。截至发稿，该股报5.28美元/股，成交量79.3954万股，换手率0.56%，振幅6.65%。Aurinia Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Apollomics Inc C/Wts 01/04/2028 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为122.46%、113.38%、73.96%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、Mei Pharma, Inc.、木薯科学，振幅分别为44.07%、37.06%、33.41%。Aurinia Pharmaceuticals Inc公司简介：Aurinia Pharmaceuticals Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723020425af937631&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723020425af937631&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AUPH","BK4139"],"gpt_icon":0},{"id":"2432207786","title":"Aurinia Pharmaceuticals(AUPH.US)：2024年Q1财报实现营收5030.3万美元，前值为3440.","url":"https://stock-news.laohu8.com/highlight/detail?id=2432207786","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432207786?lang=zh_cn&edition=full","pubTime":"2024-05-02 18:23","pubTimestamp":1714645430,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AUPH","BK4139"],"gpt_icon":0},{"id":"2416967856","title":"HC Wainwright &amp; Co.：重申Aurinia Pharmaceuticals(AUPH.US)评级，由买入调整至买入评级, 目标价13.","url":"https://stock-news.laohu8.com/highlight/detail?id=2416967856","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2416967856?lang=zh_cn&edition=full","pubTime":"2024-03-02 03:08","pubTimestamp":1709320137,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AUPH","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.auriniapharma.com","stockEarnings":[{"period":"1week","weight":0.0799},{"period":"1month","weight":0.2158},{"period":"3month","weight":0.2975},{"period":"6month","weight":0.1361},{"period":"1year","weight":-0.243},{"period":"ytd","weight":-0.2481}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aurinia Pharmaceuticals Inc.是根据《商业公司法》组建的（加拿大阿尔伯塔省）。Aurinia制药是一家完全整合的生物制药公司，专注于提供治疗目标患者群体的疗法，这些患者群体受到自身免疫、肾脏和罕见病的影响，医疗需求未得到满足。2021年1月，Aurinia制药推出了首个获得FDA批准的口服药物LUPKYNIS（voclosporin），用于治疗活动性LN成人患者。LUPKYNIS是一种口服CNI免疫抑制剂，当与霉酚酸酯（MMF）（尽管MMF目前尚未被批准）和类固醇联合使用时，已被证明可以改善LN的近期和长期结果。通过抑制钙调神经磷酸酶，LUPKYNIS降低细胞因子活化，阻断白细胞介素IL-2表达和T细胞介导的免疫反应。LUPKYNIS还可能稳定足细胞，从而防止蛋白尿。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.106403},{"month":2,"riseRate":0.5,"avgChangeRate":0.009372},{"month":3,"riseRate":0.4,"avgChangeRate":0.102117},{"month":4,"riseRate":0.6,"avgChangeRate":-0.012088},{"month":5,"riseRate":0.6,"avgChangeRate":-0.004093},{"month":6,"riseRate":0.4,"avgChangeRate":-0.030211},{"month":7,"riseRate":0.6,"avgChangeRate":0.036556},{"month":8,"riseRate":0.5,"avgChangeRate":-0.046537},{"month":9,"riseRate":0.444444,"avgChangeRate":0.078247},{"month":10,"riseRate":0.6,"avgChangeRate":0.041208},{"month":11,"riseRate":0.5,"avgChangeRate":-0.001599},{"month":12,"riseRate":0.4,"avgChangeRate":0.111111}],"exchange":"NASDAQ","name":"Aurinia Pharmaceuticals Inc","nameEN":"Aurinia Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aurinia Pharmaceuticals Inc(AUPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aurinia Pharmaceuticals Inc(AUPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aurinia Pharmaceuticals Inc,AUPH,Aurinia Pharmaceuticals Inc股票,Aurinia Pharmaceuticals Inc股票老虎,Aurinia Pharmaceuticals Inc股票老虎国际,Aurinia Pharmaceuticals Inc行情,Aurinia Pharmaceuticals Inc股票行情,Aurinia Pharmaceuticals Inc股价,Aurinia Pharmaceuticals Inc股市,Aurinia Pharmaceuticals Inc股票价格,Aurinia Pharmaceuticals Inc股票交易,Aurinia Pharmaceuticals Inc股票购买,Aurinia Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aurinia Pharmaceuticals Inc(AUPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aurinia Pharmaceuticals Inc(AUPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}